Korean J Gastroenterol.
2000 Jul;36(1):61-71.
The Pathophysiology of Nonsteroidal Anti-inflammatory Drug Induced Enteropathy in Rat
Abstract
- BACKGROUND/AIMS
The pathophysiology of nonsteroidal anti-inflammatory drug (NSAID)
induced enteropathy is still uncertain. It is proposed that an increase in intestinal
permeability due to NSAID plays an important role in it. We have investigated
the change of gastrointestinal permeability after administration of NSAID to rats.
Prostagrandin E2 (PGE2) level and gene expression of COX enzyme were also investigated.
METHODS
After administration of indomethacin 15 mg/kg, gastrointestinal permeability
was measured at the 1st day, 3rd day, 7th day, and 14th day using mixture of sucrose,
lactulose and mannitol. We evaluated PEG2 level by RIA method and gene expression
of COX enzyme by reverse transcription-polymerase chain reaction. RESULTS: The gastric
permeability was increased as 7 times as baseline (p<0.01) at 1st day and then
normalized at 7th day. On the other hand, the small intestinal permeability was
peaked at 3rd day and normalized at 14th day. PGE2 level was increased at 1st day
in both gastropathy and enteropathy lesions and the new gene expression of COX-2
enzyme was confirmed. CONCLUSIONS: The increased small intestinal permeability
by NSAID and aggravation through consequent enterohepatic recirculation of NSAID
may act as an important mechanism in NSAID-induced enteropathy. The PGE2 produced
by COX-2 may play an important role in the healing process of NSAID-induced
gastroenteropathy.